Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 2/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.65 |
| ▸ | NPC1 | O15118 | 1/20 | 0.65 |
| ▸ | USP2 | O75604 | 1/20 | 0.65 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.53 |
| ▸ | GCGR | P47871 | 9/20 | 0.52 |
| ▸ | SIRT1 | Q96EB6 | 2/20 | 0.51 |
| ▸ | KDM1A | O60341 | 2/20 | 0.50 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL684885 | 0.89 | SIRT1 (0.60) | KDM4EMEN1KMT2ANPC1USP2 | |
| SCHEMBL684975 | 0.88 | KMT2A (0.58) | KDM4EMEN1KMT2ANPC1USP2 | |
| SCHEMBL678880 | 0.88 | KMT2A (0.58) | KDM4EMEN1KMT2ANPC1USP2 | |
| SCHEMBL684865 | 0.86 | KDM4E (0.74) | KDM4EMEN1KMT2ANPC1USP2 | |
| SCHEMBL683742 | 0.85 | KMT2A (0.69) | KDM4EMEN1KMT2ANPC1USP2 | |
| SCHEMBL684848 | 0.85 | NPC1 (0.75) | KDM4EMEN1KMT2ANPC1USP2 | |
| SCHEMBL684862 | 0.84 | KDM4E (0.79) | KDM4EMEN1KMT2ANPC1USP2 | |
| SCHEMBL683747 | 0.82 | MEN1 (0.65) | KDM4EMEN1KMT2ANPC1USP2 | |
| SCHEMBL684880 | 0.81 | KMT2A (0.70) | KDM4EMEN1KMT2ANPC1USP2 | |
| SCHEMBL684570 | 0.81 | MEN1 (0.73) | KDM4EMEN1KMT2ANPC1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8461078-B2 | Fungicidal compositions including hydrazone derivatives and copper | DOW AGROSCIENCES LLC (US) | 2013-06-11 | — | — | US | disclosed |
| US-8461078-B2 | Fungicidal compositions including hydrazone derivatives and copper | DOW AGROSCIENCES LLC (US) | 2013-06-11 | — | — | US | disclosed |
| US-20120107416-A1 | FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER | DOW AGROSCIENCES LLC (US) | 2012-05-03 | — | — | US | disclosed |
| US-20120107416-A1 | FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER | DOW AGROSCIENCES LLC (US) | 2012-05-03 | — | — | US | disclosed |
| US-20120010075-A1 | SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER | DOW AGROSCIENCES LLC (US) | 2012-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120010075-A1 | SYNERGISTIC FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER | SOD1, CYP51A1, SOD3 | KDM4E 1473/4885MEN1 536/4885KMT2A 1362/4885 |
| US-20120107416-A1 | FUNGICIDAL COMPOSITIONS INCLUDING HYDRAZONE DERIVATIVES AND COPPER | SOD1, CYP51A1, CYP4Z1 | KDM4E 1286/4885MEN1 508/4885KMT2A 1224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.